National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

famotidine
A propanimidamide and histamine H2-receptor antagonist with antacid activity. As a competitive inhibitor of histamine H2-receptors located on the basolateral membrane of the parietal cell, famotidine reduces basal and nocturnal gastric acid secretion, resulting in a reduction in gastric volume, acidity, and amount of gastric acid released in response to various stimuli. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

US brand names:Pepcid
Pepcid AC



Previous:ezatiostat hydrochloride, F-18 16 alpha-fluoroestradiol, F-18 fluoroethyltyrosine, FAK inhibitor PF-00562271, falimarev
Next:Fareston, Fas receptor agonist APO010, Fasigyn, Faslodex, fazarabine

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov